BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 51 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,866,518 | +27.6% | 55,306,226 | +30.1% | 2.72% | -22.1% |
| Q2 2023 | $42,983,572 | +27.5% | 42,526,167 | +31.1% | 3.50% | +40.6% |
| Q1 2023 | $33,719,632 | +60468.4% | 32,443,000 | +62175.4% | 2.49% | -34.0% |
| Q4 2022 | $55,672 | -99.9% | 52,096 | +0.2% | 3.77% | +2.0% |
| Q3 2022 | $52,121,000 | +2.6% | 52,002 | +2.8% | 3.69% | +8.9% |
| Q2 2022 | $50,777,000 | +67.7% | 50,586 | +68.3% | 3.39% | +64.8% |
| Q1 2022 | $30,276,000 | -36.7% | 30,062 | -34.5% | 2.06% | -46.4% |
| Q4 2021 | $47,842,000 | +45.0% | 45,919 | +40.0% | 3.84% | +37.0% |
| Q3 2021 | $32,986,000 | – | 32,795 | – | 2.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 30,062 | $30,276,000 | 2.06% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 45,103,000 | $45,311,000 | 0.72% |
| MACKAY SHIELDS LLC | 76,920,000 | $77,403,000 | 0.68% |
| LOOMIS SAYLES & CO L P | 2,277,794 | $175,618,000 | 0.24% |
| KBC Group NV | 300,000 | $30,339,000 | 0.11% |
| CAMDEN ASSET MANAGEMENT L P /CA | 3,200,000 | $3,204,000 | 0.10% |
| Allianz Asset Management GmbH | 116,770,000 | $118,163,000 | 0.09% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,143,000 | $3,168,000 | 0.07% |
| Lombard Odier Asset Management (Europe) Ltd | 1,600,000 | $1,610,000 | 0.06% |
| THRIVENT FINANCIAL FOR LUTHERANS | 16,400,000 | $16,421,000 | 0.03% |